title: Re-irradiation of pituitary adenoma.
abstract: Fifteen patients initially irradiated for pituitary adenoma were subsequently treated with a second course of radiotherapy at the University of California at San Francisco between 1961 and 1989. The re-irradiation followed surgery in all but two cases. The median time to recurrence was 9 years (range 2-17) and median follow-up after the second course of radiotherapy was 10 years (range 1-30). The median initial radiation dose was 4084 cGy; that at recurrence was 4200 cGy. Local control has been maintained in 12 patients. One failed locally with a benign adenoma that was surgically salvaged. Two developed pituitary carcinomas which were poorly controlled. Of the patients who presented with visual abnormalities at the time of recurrence, 50% improved and the remainder stabilized after re-irradiation. There are no long-term visual complications. Hypopituitarism was present in nine patients prior to the second course of radiotherapy and developed in the remaining six patients after re-irradiation. Temporal lobe injury was seen in two patients. Careful analysis of each patient's pituitary and temporal lobe doses, intervals between treatments, treatment volume, neurets, relative decay factors, absolute decay factors, TDF and modified LQF values, and dose-volume relationships, revealed no correlation with complication or likelihood of local control. Repeat radiotherapy for recurrent pituitary adenoma with the doses used in these patients appears to carry acceptable risk with good local control.
authors.affiliation: Dept. of Radiation Oncology, University of California, San Francisco.
authors.forename: R
authors.initials: R
authors.lastname: Schoenthaler
authors.forename: N W
authors.initials: NW
authors.lastname: Albright
authors.forename: W M
authors.initials: WM
authors.lastname: Wara
authors.forename: T L
authors.initials: TL
authors.lastname: Phillips
authors.forename: C B
authors.initials: CB
authors.lastname: Wilson
authors.forename: D A
authors.initials: DA
authors.lastname: Larson
mesh_terms: D000236:Adenoma / Q000453:epidemiology / Q000532:radiotherapy*; D000328:Adult; D000368:Aged; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000453:epidemiology / Q000532:radiotherapy* / Q000601:surgery; D010911:Pituitary Neoplasms / Q000453:epidemiology / Q000532:radiotherapy*; D011878:Radiotherapy / Q000009:adverse effects; D012189:Retrospective Studies; D013702:Temporal Lobe / Q000528:radiation effects